Bicycle Therapeutics plc Grants Receivable
Bicycle Therapeutics plc (BCYC) had Grants Receivable of $2.30 million as of 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Notes
us-gaap:GrantsReceivable · last filed 2022-05-05
- 2022-03-31: Grants Receivable $2.30M.
- 2021-03-31: Grants Receivable $1.10M.
- 2020-09-30: Grants Receivable $2.80M.
- 2020-03-31: Grants Receivable $200.00K.
| Period end | Grants Receivable |
|---|---|
| 2022-03-31 | $2.30M 10-Q · filed 2022-05-05 |
| 2021-03-31 | $1.10M 10-Q · filed 2021-05-06 |
| 2020-09-30 | $2.80M 10-Q · filed 2020-11-05 |
| 2020-03-31 | $200.00K 10-Q · filed 2021-05-06 |
| 2018-12-31 | $0.00 10-K · filed 2021-03-11 |
| 2017-12-31 | $0.00 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |